CompanyDeals

Bio-Thera Solutions Licenses BAT2206 to World Medicine for Turkey

GE Healthcare and Sutter Health Form $1B Care Alliance
CompanyDeals

GE Healthcare and Sutter Health Form $1B Care Alliance

HutchMed's Orpathys Approved for Expanded NSCLC Indication in China
CompanyDrug

HutchMed’s Orpathys Approved for Expanded NSCLC Indication in China

Innovent's IBI343 Receives Breakthrough Therapy Designation for Pancreatic Cancer
CompanyDrug

Innovent’s IBI343 Receives Breakthrough Therapy Designation for Pancreatic Cancer

Wepon Medical's WP107 Receives FDA Approval for gMG Clinical Trial
CompanyDrug

Wepon Medical’s WP107 Receives FDA Approval for gMG Clinical Trial

Fosun Pharma Initiates Phase II Study for Glomerular Disease Treatment
CompanyDrug

Fosun Pharma Initiates Phase II Study for Glomerular Disease Treatment

Hengrui's SHR-9839 Receives NMPA Clearance for Advanced Tumors
CompanyDrug

Hengrui’s SHR-9839 Receives NMPA Clearance for Advanced Tumors

Chipscreen's Epidaza Patent Faces Invalidation Request Review
Legal / IP

Chipscreen’s Epidaza Patent Faces Invalidation Request Review

Biogen Proposes to Acquire Sage Therapeutics for $469M
CompanyDeals

Biogen Proposes to Acquire Sage Therapeutics for $469M

Medtronic Secures Exclusive Distribution Rights for Contego's Neuroguard and Excipio
CompanyDeals

Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio

Eli Lilly to Acquire Scorpion Therapeutics' STX-478 for $2.5B
CompanyDeals

Eli Lilly to Acquire Scorpion Therapeutics’ STX-478 for $2.5B

Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6B
CompanyDeals

Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6B